Cargando…

Efficacy and Safety of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Meta-Analysis

Due to a high risk of recurrent thromboembolism in patients with antiphospholipid syndrome (APS), long-term anticoagulation is recommended. For decades, vitamin K antagonists (VKAs) have been the gold standard for thromboprophylaxis in these patients. Due to the widespread use of direct oral anticoa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gullapalli, Keerthi, Prasad, Rohan M, Al-abcha, Abdullah, Hussain, Zahin, Alsouqi, Aseel, Mosalem, Osama, Hrinczenko, Borys
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587712/ https://www.ncbi.nlm.nih.gov/pubmed/36299971 http://dx.doi.org/10.7759/cureus.29449

Ejemplares similares

Severe Epistaxis Secondary to Dabrafenib and Trametinib Toxicity in Non-small Cell Lung Carcinoma With Small Bowel Metastasis
por: Gullapalli, Keerthi, et al.
Publicado: (2021)

Extra-Axial Skeletal Metastasis of Malignant Melanoma: Case Report and Literature Review
por: Gullapalli, Keerthi, et al.
Publicado: (2022)

A Rare Case of Advanced Synchronous Primary Ovarian and Cervical Cancer
por: Abdelsamia, Mahmoud, et al.
Publicado: (2022)

Role of Direct Oral Anticoagulation Agents as Thromboprophylaxis in Antiphospholipid Syndrome
por: Arora, Shreya, et al.
Publicado: (2021)

Placental and Breast Metastasis of Squamous Cell Carcinoma in a Patient With Recurrent Respiratory Papillomatosis
por: Gogineni, Venumadhavi, et al.
Publicado: (2023)

Lack of efficacy of direct oral anticoagulants compared to warfarin in antiphospholipid antibody syndrome
por: Giarretta, Igor, et al.
Publicado: (2022)

Thrombocytopenia Due to Direct Oral Anticoagulation and Low-Molecular-Weight Heparin
por: Tucker, Madeline, et al.
Publicado: (2021)

Drug Use Evaluation of Direct Oral Anticoagulants (DOACs) in Patients With Advanced Cirrhosis
por: Jarboe, Lindsey, et al.
Publicado: (2022)

Efficacy and Safety of Novel Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
por: Basu Roy, Prithvi, et al.
Publicado: (2023)

Demographic, Clinical, and Serological Characteristics of Antiphospholipid Syndrome Patients From the Anticoagulation Clinic of Hospital Universitario San Vicente Fundación, Medellín, Colombia
por: Álvarez-López, Santiago, et al.
Publicado: (2023)

Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance
por: Fazili, Masarret, et al.
Publicado: (2019)

Comparative Efficacy of Direct Oral Anticoagulants and Low-Molecular-Weight Heparin in Cancer-Associated Thromboembolism: A Systematic Review and Meta-Analysis
por: Patel, Tirath, et al.
Publicado: (2023)

Use of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Comparison of the International Guidelines
por: Pastori, Daniele, et al.
Publicado: (2021)

Usage of Direct Acting Oral Anticoagulants in Cirrhotic and Non-Cirrhotic Portal Vein Thrombosis: A Systematic Review
por: Gupta, Sachin, et al.
Publicado: (2021)

A Difficult and Rare Case of Warfarin Refractory Antiphospholipid Syndrome Presenting With Catastrophic Antiphospholipid Syndrome Complicated by Gastrointestinal Bleeding
por: Lim, William, et al.
Publicado: (2021)

Comparing the efficacy and safety of direct oral anticoagulants versus Vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis
por: Wu, Xiaoling, et al.
Publicado: (2022)

Successful secondary thromboprophylaxis with direct oral anticoagulants for a patient with catastrophic antiphospholipid syndrome: A case report
por: Dinh, Nhan Hieu, et al.
Publicado: (2020)

Direct oral anticoagulants versus vitamin K antagonists in patients with antiphospholipid syndrome: systematic review and meta-analysis
por: Koval, Nazariy, et al.
Publicado: (2021)

Antiphospholipid antibodies in pulmonary embolism treated with direct oral anticoagulants: Prevalence data from unselected consecutive patients
por: Justinussen, Tummas, et al.
Publicado: (2023)

Anticoagulant Therapy in Patients with Antiphospholipid Syndrome
por: Capecchi, Marco, et al.
Publicado: (2022)

Neurological and Neuropsychiatric Manifestations of Antiphospholipid-Antibody Syndrome (APS)
por: Asif, Saba, et al.
Publicado: (2022)

An Unusual Case of Catastrophic Antiphospholipid Syndrome in an Elderly Man
por: Lam, Kayla, et al.
Publicado: (2023)

Embolic Phenomena of Libman-Sacks Endocarditis and Antiphospholipid Syndrome
por: Gorantla, Asher, et al.
Publicado: (2023)

A Rare Rheumatologic Case of Catastrophic Antiphospholipid Syndrome
por: Maheshwari, Mani, et al.
Publicado: (2023)

Direct oral anticoagulants vs. vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis
por: Shah, Bidhan Bikram, et al.
Publicado: (2023)

Tongue Stiffness as Presentation of Antiphospholipid Syndrome: A Case Report
por: Rajevac, Hana, et al.
Publicado: (2020)

Antiphospholipid antibodies and anticoagulant therapy: capillaroscopic findings
por: Ferrari, Giorgia, et al.
Publicado: (2021)

Laboratory Diagnosis of Antiphospholipid Syndrome in Anticoagulated Patients
por: Tripodi, Armando, et al.
Publicado: (2023)

Therapeutic Challenges with Catastrophic Antiphospholipid Antibody Syndrome: A Case Report
por: Harne, Prateek, et al.
Publicado: (2020)

A Rare Case of Simultaneous Evans Syndrome and Primary Antiphospholipid Syndrome
por: Patel, Bhamini P, et al.
Publicado: (2020)

Suspected COVID-19 Immunization-Induced Probable Catastrophic Antiphospholipid Syndrome
por: Seeley, Elizabeth A, et al.
Publicado: (2022)

Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature: Comment
por: Cohen, Hannah, et al.
Publicado: (2017)

The efficacy and safety of out-hospital anticoagulation therapy with direct oral anticoagulant for COVID-19
por: Geng, Yu, et al.
Publicado: (2023)

Acute Levetiracetam-Induced Thrombocytopenia in an Anticoagulated Immunocompetent Patient
por: Nwaedozie, Somto T, et al.
Publicado: (2021)

CHARACTERISTICS, TREATMENTS, AND OUTCOMES OF COVID-19-INFECTED PATIENTS ADMITTED TO THE ICU OF A TERTIARY CARE CENTER IN LANSING, MICHIGAN
por: Raziq, Fazal, et al.
Publicado: (2020)

Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2021)

Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia
por: Shovlin, C. L., et al.
Publicado: (2019)

Safety of direct oral anticoagulants in patients with advanced liver disease
por: Semmler, Georg, et al.
Publicado: (2021)

Effectiveness and safety of self-managed oral anticoagulant therapy compared with direct oral anticoagulants in patients with atrial fibrillation
por: Grove, Erik Lerkevang, et al.
Publicado: (2018)

Antiphospholipid Syndrome Secondary to Lupus Anticoagulant: Case Report for Clinical Anticoagulation Determination
por: Lambroussis, Constantino G, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o7ns605fr716bl7ifqj1nq96d4